ABEONA THERAPEUTICS INC. Loans Payable, Current
ABEONA THERAPEUTICS INC. (ABEO) had Loans Payable, Current of $1.76 million as of 2021-06-30, per its 10-Q filed 2021-07-28.
Discontinued › Balance Sheet › Liabilities › Liabilities, Current › Debt, Current › Long-Term Debt and Lease Obligation, Current › Long-Term Debt, Current Maturities
us-gaap:LoansPayableCurrent · last filed 2022-03-31
- 2021-06-30: Loans Payable, Current $1.76M.
- 2021-03-31: Loans Payable, Current $549.00K.
- 2020-12-31: Loans Payable, Current $330.00K.
- 2020-09-30: Loans Payable, Current $1.76M.
| Period end | Loans Payable, Current |
|---|---|
| 2021-06-30 | $1.76M 10-Q · filed 2021-07-28 |
| 2021-03-31 | $549.00K 10-Q · filed 2021-05-17 |
| 2020-12-31 | $330.00K 10-K · filed 2022-03-31 |
| 2020-09-30 | $1.76M 10-Q · filed 2020-11-09 |
| 2020-06-30 | $1.76M 10-Q · filed 2020-08-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| GT Biopharma, Inc. (GTBP) | United States | $0.309B | -4.58 |
| Prelude Therapeutics Inc (PRLD) | United States | $0.318B | -7.01 |
| Evommune, Inc. (EVMN) | United States | $0.320B | -5.10 |
| BridgeBio Oncology Therapeutics, Inc. (BBOT) | United States | $0.320B | -3.35 |
| Vanda Pharmaceuticals Inc. (VNDA) | United States | $0.302B | -1.35 |
| STANDARD BIOTOOLS INC. (LAB) | United States | $0.297B | 3.80 |
| ROCKET PHARMACEUTICALS, INC. (RCKT) | United States | $0.296B | -21.78 |
| BioAge Labs, Inc. (BIOA) | United States | $0.333B | -11.88 |
| Fulcrum Therapeutics, Inc. (FULC) | United States | $0.289B | -3.28 |
| Contineum Therapeutics, Inc. (CTNM) | United States | $0.289B | -4.40 |